These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1651476)
1. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Storey A; Oates D; Banks L; Crawford L; Crook T Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. Tan TM; Gloss B; Bernard HU; Ting RC J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152 [TBL] [Abstract][Full Text] [Related]
3. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
4. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells. Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581 [TBL] [Abstract][Full Text] [Related]
5. Biologic activity of oligonucleotides with polarity and anomeric center reversal. Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
7. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene. Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339 [TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells. Sizemore N; Choo CK; Eckert RL; Rorke EA Exp Cell Res; 1998 Oct; 244(1):349-56. PubMed ID: 9770378 [TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. Hu G; Liu W; Mendelsohn J; Ellis LM; Radinsky R; Andreeff M; Deisseroth AB J Natl Cancer Inst; 1997 Sep; 89(17):1271-6. PubMed ID: 9293917 [TBL] [Abstract][Full Text] [Related]
11. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells. Venturini F; Braspenning J; Homann M; Gissmann L; Sczakiel G Nucleic Acids Res; 1999 Apr; 27(7):1585-92. PubMed ID: 10075988 [TBL] [Abstract][Full Text] [Related]
12. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Steele C; Cowsert LM; Shillitoe EJ Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572 [TBL] [Abstract][Full Text] [Related]
13. Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6/E7 oncogene expression. Finzer P; Ventz R; Kuntzen C; Seibert N; Soto U; Rösl F Virology; 2002 Dec; 304(2):265-73. PubMed ID: 12504567 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons. Khan MA; Tolleson WH; Gangemi JD; Pirisi L J Virol; 1993 Jun; 67(6):3396-403. PubMed ID: 8388505 [TBL] [Abstract][Full Text] [Related]
15. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
16. Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16. Wong YF; Chung TK; Cheung TH; Lam SK; Chang AM Med Oncol; 1994; 11(3-4):149-51. PubMed ID: 7633836 [No Abstract] [Full Text] [Related]
17. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. Peto M; Tolle-Ersü I; Kreysch HG; Klock G J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475 [TBL] [Abstract][Full Text] [Related]
18. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro. Belcastro M; Miller MR; Flynn DC; Soisson AP Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263 [TBL] [Abstract][Full Text] [Related]
19. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. De Luca A; Selvam MP; Sandomenico C; Pepe S; Bianco AR; Ciardiello F; Salomon DS; Normanno N Int J Cancer; 1997 Oct; 73(2):277-82. PubMed ID: 9335455 [TBL] [Abstract][Full Text] [Related]